New Key Statistics Module, Z-Score and F-Score
NAS:COYA Key Ratios
Market Cap $ M | 94.68 |
Enterprise Value $ M | 108.07 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.62 |
Price/Sales | 7.74 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 9.00 |
EPS (TTM) $ | -0.73 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.32 |
EV-to-EBITDA | -10.35 |
PEG | -- |
Shares Outstanding M | 15.22 |
Net Margin (%) | -105.72 |
Operating Margin % | -109.57 |
Pre-tax Margin (%) | -98.14 |
Quick Ratio | 10.43 |
Current Ratio | 10.43 |
ROA % (ttm) | -34.84 |
ROE % (ttm) | -39.88 |
ROIC % (ttm) | -809.59 |
Dividend Yield % | -- |
Altman Z-Score | 11.18 |
COYA Number of Guru Trades
COYA Volume of Guru Trades
Gurus Latest Trades with NAS:COYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:COYA is held by these investors
Total 1
Coya Therapeutics Inc Insider Transactions
No Available Data
News about NAS:COYA
Total 0- 1